The PROMISE Initiative: Accelerating Cancer Innovation
October 13, 2026 @ 09:00 – 18:30 CEST
This conference focuses on the PROMISE Cancer effort led by Swedish scientists representing Stockholm, Uppsala, Umeå, Linköping, Lund, and Gothenburg as well as SciLifeLab.
The goal of the conference is to expand the PROMISE Cancer initiative, promote its efforts, and continue building the Swedish cancer community.
About PROMISE
Precision Omics Initiative Sweden (PROMISE) is a national initiative using genomics and multiomics to understand common diseases, rare diseases, and cancer.
Program and speakers
Cancer encompasses more than 200 distinct diseases, each with widely varying prognoses, ranging from highly treatable to aggressive cancers with poor outcomes. Advances in molecular profiling hold great promise for improving diagnostics and treatment by enabling more precise, personalized approaches tailored to individual patients. Sweden has world-leading cancer registries and high-quality biobanks, creating unique opportunities for cancer research. By joining forces across the research community, we can better leverage these national strengths to benefit patients. SciLifeLab platforms support the generation, integration, and analysis of data across genomics and a broad range of other omics technologies.
Keynote
Mike Stratton, Sanger Institute
High-caliber international and national experts will present on the following main topics:
- Single cell and spatial transcriptomics and multiomics
- Cancer genomics
- Single cell and spatial transcriptomics and multiomics
- Germline cancer risk and liquid biopsies
- Functional precision cancer medicine
Poster session
Junior researchers are encouraged to participate with poster presentations.
Registration will open soon. More information will be posted here.
Scientific committee
Kerstin Lindblad-Toh
Project manager
Anna Clareborn
Google Calendar